Pharmacy, Health Sciences & Exercise Science

Retrospective Chart Review of Venous Thromboembolism Prophylaxis Pre and Post Electronic Health Record Implementation

Document Type

Oral Presentation

Location

Indianapolis, IN

Subject Area

Pharmacy, Health Sciences & Exercise Science

Start Date

11-4-2014 10:15 AM

End Date

11-4-2014 11:45 AM

Description

Background: The American College of Chest Physicians (CHEST) and National Comprehensive Cancer Network (NCCN) have published guidelines for venous thromboembolism (VTE) prophylaxis for internal medicine and oncology patients, respectfully. Adherence to these guidelines helps avoid thromboembolic complications during hospitalization. Electronic health records (EHR) have the potential to make an impact on guideline adherence, but data is lacking on this subject.

Study Objective: To determine compliance with VTE prophylaxis guidelines in the internal medicine and oncology population and if EHR implementation has any effect on the rate and appropriateness of VTE prophylaxis practices.

Methods: This study has received Institutional Review Board approval and a retrospective chart analysis was conducted. All medical and oncology patients admitted to the hospital in a two month period pre-EHR implementation and a 2 month period post-EHR implementation were evaluated for compliance with VTE prophylaxis guidelines. Patients in both groups were classified as either compliant or noncompliant with the CHEST Guidelines for non-surgical internal medicine patients and the NCCN Guidelines for oncology patients. Compliance rates will be compared between the two groups to determine whether or not the implementation of the EHR had any effect on the use of proper VTE prophylaxis. Excluded patients include those less than eighteen years old, prisoners, and pregnant women. Data that has been collected include demographics (age, sex, height, weight), indication for VTE prophylaxis, contraindications for VTE pharmacologic prophylaxis (history of bleeding and/or clotting disorders, platelet count, use of therapeutic anticoagulation, and major operation within 24 hours) and mechanical prophylaxis (hematoma and skin ulcerations or wounds), VTE prophylaxis received (including drug, dose, route, frequency, and duration), and renal function (serum creatinine and creatinine clearance calculated by the Cockcroft-Gault equation).

Results: The final results and conclusions will be presented at the Undergraduate Research Conference (URC) at Butler University on April 11, 2014.

This document is currently not available here.

Share

COinS
 
Apr 11th, 10:15 AM Apr 11th, 11:45 AM

Retrospective Chart Review of Venous Thromboembolism Prophylaxis Pre and Post Electronic Health Record Implementation

Indianapolis, IN

Background: The American College of Chest Physicians (CHEST) and National Comprehensive Cancer Network (NCCN) have published guidelines for venous thromboembolism (VTE) prophylaxis for internal medicine and oncology patients, respectfully. Adherence to these guidelines helps avoid thromboembolic complications during hospitalization. Electronic health records (EHR) have the potential to make an impact on guideline adherence, but data is lacking on this subject.

Study Objective: To determine compliance with VTE prophylaxis guidelines in the internal medicine and oncology population and if EHR implementation has any effect on the rate and appropriateness of VTE prophylaxis practices.

Methods: This study has received Institutional Review Board approval and a retrospective chart analysis was conducted. All medical and oncology patients admitted to the hospital in a two month period pre-EHR implementation and a 2 month period post-EHR implementation were evaluated for compliance with VTE prophylaxis guidelines. Patients in both groups were classified as either compliant or noncompliant with the CHEST Guidelines for non-surgical internal medicine patients and the NCCN Guidelines for oncology patients. Compliance rates will be compared between the two groups to determine whether or not the implementation of the EHR had any effect on the use of proper VTE prophylaxis. Excluded patients include those less than eighteen years old, prisoners, and pregnant women. Data that has been collected include demographics (age, sex, height, weight), indication for VTE prophylaxis, contraindications for VTE pharmacologic prophylaxis (history of bleeding and/or clotting disorders, platelet count, use of therapeutic anticoagulation, and major operation within 24 hours) and mechanical prophylaxis (hematoma and skin ulcerations or wounds), VTE prophylaxis received (including drug, dose, route, frequency, and duration), and renal function (serum creatinine and creatinine clearance calculated by the Cockcroft-Gault equation).

Results: The final results and conclusions will be presented at the Undergraduate Research Conference (URC) at Butler University on April 11, 2014.